US equities |
NVDA $236.97 ▲+1.29% SPCX $165.43 ▲+4.07% MU $1,063.49 ▼-1.06% TSLA $377.63 ▲+1.90% MSFT $526.12 ▲+1.66% INTC $116.37 ▼-2.48% SNDK $1,721.83 ▲+0.11% AMD $628.15 ▼-0.91%
FinancialContent

Articles published by Compass Pathfinder Limited

< Previous 1 2 Next >
News headline image
Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 2026
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Announces Pricing of $150 Million Public Offering
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Launches Proposed $150.0 Million Public Offering
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Participate in Two Investor Conferences in December
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Participate in Four Investor Conferences in September
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Appoints Justin Gover to Board of Directors
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
News headline image
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025
From Compass Pathfinder Limited
Via Business Wire
Tickers CMPS
< Previous 1 2 Next >